Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02687230
What this trial is testing

Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1

Who this might be right for
Pancreatic CarcinomaTumors That Express CA19-9
BioNTech Research & Development, Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT02352831
What this trial is testing

Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerCancer of PancreasCancer of the Pancreas+1 more
Washington University School of Medicine 16
Not applicableLooking for participantsNCT06706700
What this trial is testing

Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas

Who this might be right for
Intraductal Papillary Mucinous Neoplasm of PancreasPancreatic Cyst
IRCCS San Raffaele 586
Early research (Phase 1)Not Yet RecruitingNCT07650357
What this trial is testing

CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerPancreatic Carcinoma+1 more
Clasp Therapeutics, Inc. 140
Testing effectiveness (Phase 2)Ended earlyNCT01042028
What this trial is testing

A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Per Pfeiffer 39
Very early researchEnded earlyNCT04930991
What this trial is testing

High Dose Omeprazole in Patients With Pancreatic Cancer

Who this might be right for
Exocrine Pancreatic Cancer
University of Oklahoma 25
Not applicableLooking for participantsNCT07591246
What this trial is testing

Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction

Who this might be right for
Polycystic Ovary SyndromeNon-Alcoholic Fatty Pancreatic DiseaseSubclinical hypothyroïdism
Cairo University 40
Testing effectiveness (Phase 2)Looking for participantsNCT04421820
What this trial is testing

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Who this might be right for
Colorectal CancerPancreatic CancerGastric Cancers+1 more
Bold Therapeutics, Inc. 220
Not applicableUnknownNCT02220062
What this trial is testing

Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Ganglia Neurolysis to Control Pain in Inoperable Pancreatic Cancer Patients With Inadequate Pain Control by Pain Killer

Who this might be right for
Pancreatic Neoplasms
Samsung Medical Center 166
Early research (Phase 1)UnknownNCT04425876
What this trial is testing

Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd. 74
Not applicableStudy completedNCT07147374
What this trial is testing

Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncologic Outcomes

Who this might be right for
Pancreatic CancerNeoadjuvant TherapyRobotic Surgery
Peking Union Medical College Hospital 56
Testing effectiveness (Phase 2)Study completedNCT04705818
What this trial is testing

Combining Epigenetic And Immune Therapy to Beat Cancer.

Who this might be right for
Advanced Solid TumorAdvanced Colorectal CarcinomaAdvanced Soft-tissue Sarcoma+2 more
Institut Bergonié 164
Early research (Phase 1)Looking for participantsNCT07619313
What this trial is testing

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced CholangiocarcinomaLocally Advanced Pancreatic Adenocarcinoma+5 more
Jonsson Comprehensive Cancer Center 46
Testing effectiveness (Phase 2)Looking for participantsNCT06445062
What this trial is testing

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Who this might be right for
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc. 1,130
Testing effectiveness (Phase 2)Looking for participantsNCT04789486
What this trial is testing

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Who this might be right for
Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer+1 more
Dana-Farber Cancer Institute 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06166589
What this trial is testing

Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

Who this might be right for
Previously AG Chemotherapy Treated Pancreatic Cancer
Shanghai Zhongshan Hospital 19
Early research (Phase 1)UnknownNCT01218880
What this trial is testing

Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Beijing Protgen Biotechnology Development Co., Ltd. 21
Not applicableStudy completedNCT04789980
What this trial is testing

Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Boryung Pharmaceutical Co., Ltd 799
Not applicableUnknownNCT04773769
What this trial is testing

Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas

Who this might be right for
Gastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionHepatocellular Carcinoma+3 more
Auxilio Mutuo Cancer Center 54
Testing effectiveness (Phase 2)Ended earlyNCT04203641
What this trial is testing

L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Helix BioPharma Corporation 28
Next Page